Found 74 hits Enz. Inhib. hit(s) with all data for entry = 50026670 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Displacement of radiolabeled dofetilide from human ERG |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Beta-1 adrenergic receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of adrenergic beta1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of dopamine D2 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M1
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of muscarinic M1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 2B
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of 5HT2B receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of NK1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of mu opioid receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Histamine H1 receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of histamine H1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Somatostatin receptor type 4
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of sst4 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 1A
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of 5HT1A receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50261907
(3-(4-(3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl)...)Show SMILES Clc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccccc3c2)c(Cl)c1 Show InChI InChI=1S/C22H18Cl2N4O/c23-16-5-6-18(19(24)12-16)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h1-6,11-14H,7-10H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 80 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50262392
(3-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-y...)Show SMILES Fc1ccc(-c2noc(CCC(=O)Nc3cnc4ccccc4c3)n2)c(Cl)c1 Show InChI InChI=1S/C20H14ClFN4O2/c21-16-10-13(22)5-6-15(16)20-25-19(28-26-20)8-7-18(27)24-14-9-12-3-1-2-4-17(12)23-11-14/h1-6,9-11H,7-8H2,(H,24,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261909
(3-(4-(3-cyclohexyl-1,2,4-oxadiazol-5-yl)piperidin-...)Show SMILES C1CCC(CC1)c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1 Show InChI InChI=1S/C22H26N4O/c1-2-6-16(7-3-1)21-24-22(27-25-21)17-10-12-26(13-11-17)19-14-18-8-4-5-9-20(18)23-15-19/h4-5,8-9,14-17H,1-3,6-7,10-13H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261907
(3-(4-(3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl)...)Show SMILES Clc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccccc3c2)c(Cl)c1 Show InChI InChI=1S/C22H18Cl2N4O/c23-16-5-6-18(19(24)12-16)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h1-6,11-14H,7-10H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 951 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261906
(3-(4-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)pipe...)Show SMILES Clc1ccc(cc1)-c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1 Show InChI InChI=1S/C22H19ClN4O/c23-18-7-5-15(6-8-18)21-25-22(28-26-21)16-9-11-27(12-10-16)19-13-17-3-1-2-4-20(17)24-14-19/h1-8,13-14,16H,9-12H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.62E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261797
(3-(4-(3-(3-chloropyridin-4-yl)-1,2,4-oxadiazol-5-y...)Show SMILES Clc1cnccc1-c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1 Show InChI InChI=1S/C21H18ClN5O/c22-18-13-23-8-5-17(18)20-25-21(28-26-20)14-6-9-27(10-7-14)16-11-15-3-1-2-4-19(15)24-12-16/h1-5,8,11-14H,6-7,9-10H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 96 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261730
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(OC(F)(F)F)cc3c2)c(Cl)c1 Show InChI InChI=1S/C23H17ClF4N4O2/c24-19-11-15(25)1-3-18(19)21-30-22(34-31-21)13-5-7-32(8-6-13)16-9-14-10-17(33-23(26,27)28)2-4-20(14)29-12-16/h1-4,9-13H,5-8H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 419 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261728
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3c(cccc3c2)C(F)(F)F)c(Cl)c1 Show InChI InChI=1S/C23H17ClF4N4O/c24-19-11-15(25)4-5-17(19)21-30-22(33-31-21)13-6-8-32(9-7-13)16-10-14-2-1-3-18(23(26,27)28)20(14)29-12-16/h1-5,10-13H,6-9H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262565
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES CC1(C)CCCc2cc(cnc12)N1CCC(CC1)c1nc(no1)-c1ccc(F)cc1Cl Show InChI InChI=1S/C24H26ClFN4O/c1-24(2)9-3-4-16-12-18(14-27-21(16)24)30-10-7-15(8-11-30)23-28-22(29-31-23)19-6-5-17(26)13-20(19)25/h5-6,12-15H,3-4,7-11H2,1-2H3 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 722 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262564
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3CCCCc3c2)c(Cl)c1 Show InChI InChI=1S/C22H22ClFN4O/c23-19-12-16(24)5-6-18(19)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h5-6,11-14H,1-4,7-10H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 910 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262508
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccccc3c2)c(Cl)c1 Show InChI InChI=1S/C22H18ClFN4O/c23-19-12-16(24)5-6-18(19)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h1-6,11-14H,7-10H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.03E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262507
(3-((R)-3-((3-(2-chloro-4-fluorophenyl)-1,2,4-oxadi...)Show SMILES Fc1ccc(-c2noc(C[C@H]3CCN(C3)c3cnc4ccccc4c3)n2)c(Cl)c1 |r| Show InChI InChI=1S/C22H18ClFN4O/c23-19-11-16(24)5-6-18(19)22-26-21(29-27-22)9-14-7-8-28(13-14)17-10-15-3-1-2-4-20(15)25-12-17/h1-6,10-12,14H,7-9,13H2/t14-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.69E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262506
(3-((S)-3-((3-(2-chloro-4-fluorophenyl)-1,2,4-oxadi...)Show SMILES Fc1ccc(-c2noc(C[C@@H]3CCN(C3)c3cnc4ccccc4c3)n2)c(Cl)c1 |r| Show InChI InChI=1S/C22H18ClFN4O/c23-19-11-16(24)5-6-18(19)22-26-21(29-27-22)9-14-7-8-28(13-14)17-10-15-3-1-2-4-20(15)25-12-17/h1-6,10-12,14H,7-9,13H2/t14-/m0/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262450
((+/-)-N-((1R,2R)-2-(3-(2-chloro-4-fluorophenyl)-1,...)Show SMILES Fc1ccc(-c2noc(n2)[C@@H]2CCC[C@H]2Nc2cnc3ccccc3c2)c(Cl)c1 |r| Show InChI InChI=1S/C22H18ClFN4O/c23-18-11-14(24)8-9-16(18)21-27-22(29-28-21)17-5-3-7-20(17)26-15-10-13-4-1-2-6-19(13)25-12-15/h1-2,4,6,8-12,17,20,26H,3,5,7H2/t17-,20-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.23E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262449
(CHEMBL514706 | N-(4-(3-(2-chloro-4-fluorophenyl)-1...)Show SMILES CC(C)(CCc1nc(no1)-c1ccc(F)cc1Cl)Nc1cnc2ccccc2c1 Show InChI InChI=1S/C22H20ClFN4O/c1-22(2,27-16-11-14-5-3-4-6-19(14)25-13-16)10-9-20-26-21(28-29-20)17-8-7-15(24)12-18(17)23/h3-8,11-13,27H,9-10H2,1-2H3 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262448
((+/-) N-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxad...)Show SMILES CC(CCc1nc(no1)-c1ccc(F)cc1Cl)Nc1cnc2ccccc2c1 Show InChI InChI=1S/C21H18ClFN4O/c1-13(25-16-10-14-4-2-3-5-19(14)24-12-16)6-9-20-26-21(27-28-20)17-8-7-15(23)11-18(17)22/h2-5,7-8,10-13,25H,6,9H2,1H3 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.56E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262447
(CHEMBL477993 | N-(3-(3-(2-chloro-4-fluorophenyl)-1...)Show SMILES Fc1ccc(-c2noc(CCCNc3cnc4ccccc4c3)n2)c(Cl)c1 Show InChI InChI=1S/C20H16ClFN4O/c21-17-11-14(22)7-8-16(17)20-25-19(27-26-20)6-3-9-23-15-10-13-4-1-2-5-18(13)24-12-15/h1-2,4-5,7-8,10-12,23H,3,6,9H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 472 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262392
(3-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-y...)Show SMILES Fc1ccc(-c2noc(CCC(=O)Nc3cnc4ccccc4c3)n2)c(Cl)c1 Show InChI InChI=1S/C20H14ClFN4O2/c21-16-10-13(22)5-6-15(16)20-25-19(28-26-20)8-7-18(27)24-14-9-12-3-1-2-4-17(12)23-11-14/h1-6,9-11H,7-8H2,(H,24,27) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 559 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262508
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccccc3c2)c(Cl)c1 Show InChI InChI=1S/C22H18ClFN4O/c23-19-12-16(24)5-6-18(19)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h1-6,11-14H,7-10H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262506
(3-((S)-3-((3-(2-chloro-4-fluorophenyl)-1,2,4-oxadi...)Show SMILES Fc1ccc(-c2noc(C[C@@H]3CCN(C3)c3cnc4ccccc4c3)n2)c(Cl)c1 |r| Show InChI InChI=1S/C22H18ClFN4O/c23-19-11-16(24)5-6-18(19)22-26-21(29-27-22)9-14-7-8-28(13-14)17-10-15-3-1-2-4-20(15)25-12-17/h1-6,10-12,14H,7-9,13H2/t14-/m0/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262505
((+/-)-N-(((1S,2S)-2-(3-(2-chloro-4-fluorophenyl)-1...)Show SMILES Fc1ccc(-c2noc(n2)[C@H]2C[C@@H]2CNc2cnc3ccccc3c2)c(Cl)c1 |r| Show InChI InChI=1S/C21H16ClFN4O/c22-18-9-14(23)5-6-16(18)20-26-21(28-27-20)17-8-13(17)10-24-15-7-12-3-1-2-4-19(12)25-11-15/h1-7,9,11,13,17,24H,8,10H2/t13-,17+/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50262449
(CHEMBL514706 | N-(4-(3-(2-chloro-4-fluorophenyl)-1...)Show SMILES CC(C)(CCc1nc(no1)-c1ccc(F)cc1Cl)Nc1cnc2ccccc2c1 Show InChI InChI=1S/C22H20ClFN4O/c1-22(2,27-16-11-14-5-3-4-6-19(14)25-13-16)10-9-20-26-21(28-29-20)17-8-7-15(24)12-18(17)23/h3-8,11-13,27H,9-10H2,1-2H3 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Somatostatin receptor type 4
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at sst4 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Beta-1 adrenergic receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at adrenergic beta1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at dopamine D2 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 1A
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at 5HT1A receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 2B
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at 5HT2B receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at NK1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at mu opioid receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Histamine H1 receptor
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at histamine H1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M1
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at muscarinic M1 receptor (unknown origin) |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50261908
(3-(4-(3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl)pipe...)Show SMILES Fc1ccccc1-c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1 Show InChI InChI=1S/C22H19FN4O/c23-19-7-3-2-6-18(19)21-25-22(28-26-21)15-9-11-27(12-10-15)17-13-16-5-1-4-8-20(16)24-14-17/h1-8,13-15H,9-12H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50261909
(3-(4-(3-cyclohexyl-1,2,4-oxadiazol-5-yl)piperidin-...)Show SMILES C1CCC(CC1)c1noc(n1)C1CCN(CC1)c1cnc2ccccc2c1 Show InChI InChI=1S/C22H26N4O/c1-2-6-16(7-3-1)21-24-22(27-25-21)17-10-12-26(13-11-17)19-14-18-8-4-5-9-20(18)23-15-19/h4-5,8-9,14-17H,1-3,6-7,10-13H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50261910
(3-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1...)Show InChI InChI=1S/C19H22N4O/c1-13(2)18-21-19(24-22-18)14-7-9-23(10-8-14)16-11-15-5-3-4-6-17(15)20-12-16/h3-6,11-14H,7-10H2,1-2H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.44E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50262392
(3-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-y...)Show SMILES Fc1ccc(-c2noc(CCC(=O)Nc3cnc4ccccc4c3)n2)c(Cl)c1 Show InChI InChI=1S/C20H14ClFN4O2/c21-16-10-13(22)5-6-15(16)20-25-19(28-26-20)8-7-18(27)24-14-9-12-3-1-2-4-17(12)23-11-14/h1-6,9-11H,7-8H2,(H,24,27) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50261729
(6-chloro-3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-o...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(Cl)cc3c2)c(Cl)c1 Show InChI InChI=1S/C22H17Cl2FN4O/c23-15-1-4-20-14(9-15)10-17(12-26-20)29-7-5-13(6-8-29)22-27-21(28-30-22)18-3-2-16(25)11-19(18)24/h1-4,9-13H,5-8H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50262508
(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)Show SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccccc3c2)c(Cl)c1 Show InChI InChI=1S/C22H18ClFN4O/c23-19-12-16(24)5-6-18(19)21-26-22(29-27-21)14-7-9-28(10-8-14)17-11-15-3-1-2-4-20(15)25-13-17/h1-6,11-14H,7-10H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50262506
(3-((S)-3-((3-(2-chloro-4-fluorophenyl)-1,2,4-oxadi...)Show SMILES Fc1ccc(-c2noc(C[C@@H]3CCN(C3)c3cnc4ccccc4c3)n2)c(Cl)c1 |r| Show InChI InChI=1S/C22H18ClFN4O/c23-19-11-16(24)5-6-18(19)22-26-21(29-27-22)9-14-7-8-28(13-14)17-10-15-3-1-2-4-20(15)25-12-17/h1-6,10-12,14H,7-9,13H2/t14-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Agonist activity at human CB2 receptor assessed as inhibition of forskolin-induced increase in intracellular cAMP |
Bioorg Med Chem Lett 18: 4267-74 (2008)
Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 |
More data for this Ligand-Target Pair | |